CIK 0001839970 · <br>Emerging growth company
BlossomHill Therapeutics, Inc.
Sign in to watch- Ticker
- BLSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851578711
- Phone
- 858-732-3880
- Business address
- 10255 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | Cui Jingrong Jean President and CEO | Conversion · Series B Preferred Stock | −124,779 | 0 | ||
| 2026-08-10 | Li Yishan Executive Chairman | Conversion | +1,600,682 | 1,600,682 | ||
| 2026-08-10 | Li Yishan Executive Chairman | Conversion | +113,435 | 1,714,117 | ||
| 2026-08-10 | Li Yishan Executive Chairman | Conversion | +124,779 | 124,779 | ||
| 2026-08-10 | Li Yishan Executive Chairman | Conversion · Series Angel Preferred Stock | −1,600,682 | 0 | ||
| 2026-08-10 | Li Yishan Executive Chairman | Conversion · Series B Preferred Stock | −113,435 | 0 | ||
| 2026-08-10 | Li Yishan Executive Chairman | Conversion · Series B Preferred Stock | −124,779 | 0 | ||
| 2026-08-10 | Keyes Jason A Chief Financial Officer | Purchase | +700 | $16.00 | $11K | 700 |
| 2026-08-10 | Schmid John P. Director | Purchase | +6,000 | $16.00 | $96K | 6,000 |
| 2026-08-10 | Chen Bihua Director | Conversion | +1,599,993 | 1,599,993 | ||
| 2026-08-10 | Chen Bihua Director | Conversion | +1,701,541 | 3,301,534 | ||
| 2026-08-10 | Chen Bihua Director | Purchase | +312,500 | $16.00 | $5.0M | 3,614,034 |
| 2026-08-10 | Chen Bihua Director | Conversion · Series A Preferred Stock | −1,599,993 | 0 | ||
| 2026-08-10 | Chen Bihua Director | Conversion · Series B Preferred Stock | −1,701,541 | 0 | ||
| 2026-08-07 | Liptak Vincent Paul General Counsel | Purchase | +2,500 | $15.80 | $40K | 109,212 |
| 2026-08-06 | Oxnard Geoffrey Raymond Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +61,783 | 61,783 | ||
| 2026-08-06 | Liptak Vincent Paul General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +46,561 | 46,561 | ||
| 2026-08-06 | Agrawal Sundeep Director | Grant or award · Director Stock Option (Right to Buy) | +23,904 | 23,904 | ||
| 2026-08-06 | Cui Jingrong Jean President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +676,205 | 676,205 | ||
| 2026-08-06 | Li Yishan Executive Chairman | Grant or award · Employee Stock Option (Right to Buy) | +112,701 | 112,701 |
Page 2 of 3 · 43 trades